An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System (Simplify).
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2013
At a glance
- Drugs Norethisterone (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Acronyms Simplify
- Sponsors Actavis Inc
- 01 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2011 Planned End Date changed from 1 Feb 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 05 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.